Trademark Overview
On Friday, March 13, 2026, a trademark application was filed for ARBOR with the United States Patent and Trademark Office. The USPTO has given the ARBOR trademark a serial number of 99701154. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Friday, March 13, 2026. This trademark is owned by Arbor Biotechnologies, Inc.. The ARBOR trademark is filed in the Pharmaceutical Products, Treatment & Processing of Materials Services, and Computer & Software Services & Scientific Services categories with the following description:
engineered nucleic acid sequences for medical purposes; nucleases, fusion proteins, RNAs and biomolecular complexes for modification of cellular genome; gene editing agents for modifying RNA sequences; gene editing agents for modifying DNA sequences at genomic target sites; engineered biomolecular complexes comprised of fusion proteins and RNAs used for modifying nucleic acid sequences in human genomes; engineered biomolecular compound for enhanced regulation and correction of gene expression and mutations, excision and insertion of DNA sequences, and delivery of whole genes and nucleic acid sequences to target sites; gene therapy and cell therapy products in the nature of DNA editing complexes targeting genomic sites
bioengineering of proteins, nucleic acids, RNAs, and gene editing complexes used in genomic engineering; providing medical scientific research information in the fields of gene editing technologies and genomic engineering
custom biomanufacturing of gene editing complexes; custom biomanufacturing of engineered fusion proteins and nucleic acids for use in Cell and Gene Therapy (CGT)
